Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial-Reference-Cited by-同舟云学术

Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial

Published:2017-12-13 Issue:3 Volume:32 Page:496-503
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Darvishi-Khezri Hadi¹,Salehifar Ebrahim²^ORCID,Kosaryan Mehrnoush³,Karami Hossein³,Mahdavi Mohammadreza⁴,Alipour Abbas⁵,Aliasgharian Aily⁶

Affiliation:

1. Department of Nursing, Sari Branch; Islamic Azad University; Sari Iran

2. Department of Clinical Pharmacology, Thalassemia Research Center, Hemoglobinopathy Institute; Mazandaran University of Medical Sciences; Mazandaran Sari Iran

3. Department of Pediatrics, Thalassemia Research Center, Hemoglobinopathy Institute; Mazandaran University of Medical Sciences; Mazandaran Sari Iran

4. PhD in Medical Genetics, Thalassemia Research Center, Hemoglobinopathy Institute; Mazandaran University of Medical Sciences; Mazandaran Sari Iran

5. Department of Community Medicine, Thalassemia Research Center, Hemoglobinopathy Institute; Mazandaran University of Medical Sciences; Mazandaran Sari Iran

6. Student Research Committee, MSc in Medical Microbiology, Thalassemia Research Center, Hemoglobinopathy Institute; Mazandaran University of Medical Sciences; Mazandaran Sari Iran

Funder

Mazandaran University of Medical Sciences

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ptr.5995/fullpdf

Reference38 articles.

1. Milk thistle in liver diseases: Past, present, future;Abenavoli;Phytotherapy Research,2010

2. Therapeutic effects of deferoxamine and silymarin versus deferoxamine alone in β-thalassemia major based on findings of liver MRI;Adibi;Journal of Research in Medical Sciences,2012

3. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants;Amer;British Journal of Haematology,2006

4. Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: The impact of silymarin therapy;Balouchi;Immunopharmacology and Immunotoxicology,2014

5. Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C;Bares;Journal of Clinical Gastroenterology,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grape seed extract in combination with deferasirox ameliorates iron overload, oxidative stress, inflammation, and liver dysfunction in beta thalassemia children;Complementary Therapies in Clinical Practice;2023-11

2. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia;Cochrane Database of Systematic Reviews;2023-03-06

3. Holy Thistle;Essentials of Medicinal and Aromatic Crops;2023

4. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms;Biomedicine & Pharmacotherapy;2022-10

5. Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia;Clinical Case Reports;2022-01